VISHEE(SH:688580) Zheng Quan Zhi Xing·2025-09-02 16:26Core Viewpoint - The announcement details the completion of share reduction plans by key executives of Nanjing Weisi Medical Technology Co., Ltd, including specific share amounts and percentages involved in the transactions [1][2][3]. Summary by Relevant Sections Shareholding Background - Before the reduction, the company's board member and CFO, Chen Lili, held 30,625 shares, representing 0.0320% of the total shares. Core technical personnel and vice president, Qiu Kai, held 136,500 shares, representing 0.1425% of the total shares. Both holdings originated from a restricted stock incentive plan [1][2]. Reduction Plan Implementation Results - Chen Lili planned to reduce up to 7,656 shares (0.0080% of total shares), while Qiu Kai planned to reduce up to 34,125 shares (0.0356% of total shares). The reduction period was set for three months following a 15-day post-announcement period [1][2]. Actual Reduction Details - As of the announcement date, Chen Lili reduced 7,600 shares (0.0079% of total shares) and Qiu Kai reduced 34,000 shares (0.0355% of total shares). The reductions were completed through centralized bidding on the Shanghai Stock Exchange [2][3]. - Chen Lili's shares were sold at a price range of 48.40 to 53.46 CNY per share, totaling 400,620.80 CNY. Qiu Kai's shares were sold at a price range of 45.98 to 46.90 CNY per share, totaling 1,582,713.90 CNY [3].